Procurement Summary
Country: USA
Summary: Request for Information on Cdc Procurement of Clinical Specimens
Deadline: 22 May 2026
Posting Date: 24 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140048410
Document Ref. No.: 412026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
The primary goal of this RFI is to gather information regarding the acquisition of clinical specimens or synthetic specimen matrices for the development and validation of diagnostic tests. This initiative aligns with the National Biodefense Strategy and Implementation Plan, which outlines a broad national vision for enhancing pandemic preparedness and countering biological threats, including building specimen procurement capabilities to support rapid medical countermeasure development.
This RFI is for market research only and does not commit the Government to issue a solicitation, make an award, or pay any costs associated with responding to this RFI. The information submitted in all responses will be utilized to help the Government further define its requirements and develop acquisition strategies. All submitted information shall remain with the Government and will not be returned.
Notice ID: 412026
Department/Ind. Agency: health and human services, department of
Sub-tier: centers for disease control and prevention
Office: cdc office of acquisition services
Inactive Dates: jun 06, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice
Documents.zip